Rowsey, K., Khan, A., Brassfield, J., Rashid, M., Duncan, J., & Vassar, M. (2025). Lowering pain and inflammation drug costs: Evaluating the impact of a cost plus drug company model Open Access. Pain Medicine, 26(9), 607. https://doi.org/10.1093/pm/pnaf034
Chicago Style (17th ed.) CitationRowsey, Kaylyn, Adam Khan, Jillian Brassfield, Matthew Rashid, Jacob Duncan, and Matt Vassar. "Lowering Pain and Inflammation Drug Costs: Evaluating the Impact of a Cost Plus Drug Company Model Open Access." Pain Medicine 26, no. 9 (2025): 607. https://doi.org/10.1093/pm/pnaf034.
MLA (9th ed.) CitationRowsey, Kaylyn, et al. "Lowering Pain and Inflammation Drug Costs: Evaluating the Impact of a Cost Plus Drug Company Model Open Access." Pain Medicine, vol. 26, no. 9, 2025, p. 607, https://doi.org/10.1093/pm/pnaf034.